Solvay S.A. operates as a chemical and pharmaceutical group worldwide. It operates in three segments: Pharmaceuticals, Chemicals, and Plastics. The Pharmaceuticals segment offers various products in the areas of cardiometabolics, neuroscience, flu vaccines, pancreatic enzymes, gastroenterology, and women’s and men’s health. The Chemicals segment provides soda ash, caustic soda, hydrogen peroxide, persalts, technical grade barium and strontium carbonates, and sodium hypochlorite, as well as fluorinated products, sodium bicarbonate, ultra-pure barium and strontium carbonates, caprolactones, and ultra-pure grades of hydrogen peroxide. The Plastics segment offers specialty, such as fluorinated polymers, elastopolymers and fluids, barrier materials, polyarylamides, polysulfones, polyamides, liquid crystal polymers, and fuel systems, as well as vinyls and pipes and fittings. The company serves glass, chemical, detergents, cleaning and hygiene products, paper, construction and architecture, human health, water and environment, automobile human and animal, food processing, electricity and electronics, other industries. Solvay was founded in 1863 and is headquartered in Brussels, Belgium.